论文部分内容阅读
我院于1983年7～12月应用支链氨基酸注射液治疗5例肝性脑病,有较好的苏醒效果,现报告如下。一、研究对象:全部病例诊断均按1978年全国肝炎会议拟定的标准,肝昏迷按 Parson-Smith 五级分类法分类。治疗组5例均为男性,诊为急性重肝Ⅲ级脑病1例,亚急性重肝Ⅲ级脑病1例,慢性重肝Ⅲ级与Ⅳ级脑病各1例,肝硬化Ⅱ级脑病1例。对照组(与治疗组同期入院未用支链氨基酸注射液治疗的病例)
Our hospital in July 1983 to December application of branched-chain amino acid injection treatment of 5 cases of hepatic encephalopathy, a better wake effect, are as follows. First, the research object: All cases diagnosed according to the standards formulated by the National Hepatitis Conference in 1978, liver coma by Parson-Smith five classification. All the 5 patients in the treatment group were male. The patients were diagnosed as acute severe grade Ⅲ encephalopathy in 1 case, subacute severe grade Ⅲ encephalopathy in 1 case, chronic severe grade Ⅲ and Ⅳ encephalopathy in 1 case, and cirrhosis grade Ⅱ encephalopathy in 1 case. Control group (with the treatment group hospitalized during the same period without branched chain amino acid injection treatment of cases)